Cian Healthcare Ltd Stock Price Today (NSE: CHCL)
Fundamental Score
Cian Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Cian Healthcare Ltd share price today is ₹8.26, up +0.00% on NSE/BSE as of 22 June 2026. Cian Healthcare Ltd (CHCL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹14.60 (Cr). The 52-week high for CHCL share price is ₹73.03 and the 52-week low is ₹3.11. The company has a Return on Equity (ROE) of -14.27% and a debt-to-equity ratio of 1.05.
Cian Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Cian Healthcare Ltd share price chart: 0.00% return over the past month. 52-week high ₹73.03, 52-week low ₹3.11.
Cian Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | 0.00 (Cr) |
Cian Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | +0.00% | |
| ₹8.26 | ₹8.26 | ₹8.26 | ₹8.26 | +0.00% | |
| ₹73.03 | ₹73.03 | ₹7.50 | ₹8.26 | -88.69% | |
| ₹73.03 | ₹73.03 | ₹73.03 | ₹73.03 | +0.00% | |
| ₹73.03 | ₹73.03 | ₹73.03 | ₹73.03 | +0.00% | |
| ₹5.58 | ₹73.03 | ₹4.74 | ₹73.03 | +1208.82% | |
| ₹5.84 | ₹5.84 | ₹4.72 | ₹5.48 | -6.16% | |
| ₹7.23 | ₹7.66 | ₹5.95 | ₹5.95 | -17.70% | |
| ₹5.04 | ₹7.09 | ₹4.94 | ₹7.09 | +40.67% | |
| ₹3.35 | ₹4.95 | ₹3.35 | ₹4.95 | +47.76% | |
| ₹3.28 | ₹3.34 | ₹3.11 | ₹3.29 | +0.30% | |
| ₹4.32 | ₹4.32 | ₹3.34 | ₹3.34 | -22.69% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Microcap pharma turnaround is a coin flip with bankruptcy risk.
WHAT'S HAPPENING NOW
Cian Healthcare received trading approval for 25,000,000 equity shares. The company appointed Mr. Chirag Mehta as Head-Operations and Mr. Ravikant Chavan as IT-Head, effective March 16, 2026. These appointments signal a potential operational and technological revamp.
CORE STORY
Cian Healthcare is attempting a turnaround story post-insolvency, fueled by new management and potential restructuring. The market is likely pricing in the hope of a successful turnaround, not current earnings power.
- Restructuring underway
- New management appointed
- Pharma sector showing positive trends
- Successful turnaround execution
- Order wins
- Improved financial performance
- Microcap liquidity risk
- History of losses
- High promoter pledging
- Negative interest coverage
No FII/DII activity. Promoter holding stable at 27.11%.
Indian pharma sector has tailwinds, but US tariff risks exist.
Free Cash Flow 5Y is ₹32.96 Cr, but inconsistent profitability raises concerns.
3-6 month thesis hinges on successful restructuring and operational improvements. Watch for order wins and financial performance.
Primary Thesis Risk
Failure to turnaround will likely lead to bankruptcy.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Cian Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Cian Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CHCL across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Strong Cash Generation (₹32.96 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Risk Factors
10 factors identified
Below-Average Return on Equity (-14.27%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-5.70%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-20.75%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-38.98%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-11.55% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Elevated Debt Levels (D/E: 1.05)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-133.33x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Low Promoter Commitment (27.11%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
High Share Pledging Risk (34.48%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Cian Healthcare Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Cian Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Cian Healthcare LtdCian Healthcare...Selected✓ CHCL • 542678 | 0/100 | ₹8.26₹8 | ₹14.60₹14.60 | — — | -14.27%Poor -14.27% Poor | -5.70%Poor -5.70% Poor | 1.05Average 1.1 Average | — — | -11.55%Poor -11.55% Poor | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Cian Healthcare Ltd Quarterly Performance
Latest quarterly metrics for CHCL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-38.98%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-20.75%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-11.55%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Cian Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for CHCL — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Cian Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Cian Healthcare Ltd (CHCL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Cian Healthcare Ltd
About CHCL (Cian Healthcare Ltd)
Cian Healthcare Ltd is a dynamic pharmaceutical company dedicated to improving lives through innovative healthcare solutions. Operating primarily in India, CHCL focuses on the enti...re lifecycle of drug development, from rigorous research and meticulous development to efficient manufacture and strategic marketing. The company prides itself on its commitment to quality and patient well-being, striving to provide accessible and affordable medications that address a wide spectrum of health needs. CHCL aims to be a trusted partner for healthcare professionals and patients alike, driven by a mission to enhance the quality of life through pharmaceutical excellence. CHCL's product portfolio reflects its comprehensive approach to healthcare, encompassing a diverse range of therapeutic areas. From specialized treatments in gynecology and critical cardio-diabetic medications to essential orthopedic and pediatric formulations, CHCL caters to the varied needs of a growing population. The company also recognizes the increasing importance of preventative care, offering a range of vitamins, nutrients, and dermacosmetic products designed to promote overall health and well-being. With a commitment to addressing evolving healthcare challenges, CHCL continuously expands its product offerings through active research and strategic collaborations. Beyond traditional pharmaceuticals, Cian Healthcare Ltd acknowledges and addresses specific unmet medical needs within the community. This proactive approach is exemplified through their commitment to providing specialized products in areas such as male and female infertility, contributing to reproductive wellness. Furthermore, the company recognizes the importance of cognitive health and offers products aimed at energy boosting and supporting individuals with autism. By focusing on these crucial areas, CHCL demonstrates a dedication to comprehensive healthcare and a commitment to improving the lives of individuals across diverse demographics and needs.
Company Details
Key Leadership
Latest News
CHCL Share Price: Frequently Asked Questions
What is the current share price of Cian Healthcare Ltd?
Cian Healthcare Ltd (CHCL) trades at ₹8.26 on NSE and BSE. Market cap ₹14.60 (Cr). Educational data only.
What is the P/E ratio of Cian Healthcare Ltd?
Cian Healthcare Ltd has a P/E of N/Ax vs industry average 31.77x.
What is the Bull Run score for Cian Healthcare Ltd?
Cian Healthcare Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Cian Healthcare Ltd pay dividends?
Cian Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Cian Healthcare Ltd?
Cian Healthcare Ltd has ROE of -14.27%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Cian Healthcare Ltd?
Cian Healthcare Ltd has debt-to-equity of 1.05.
Is Cian Healthcare Ltd a good investment?
Bull Run gives Cian Healthcare Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.